CN107548398A - 苯并氧杂硼杂环戊烯化合物及其用途 - Google Patents

苯并氧杂硼杂环戊烯化合物及其用途 Download PDF

Info

Publication number
CN107548398A
CN107548398A CN201680021488.3A CN201680021488A CN107548398A CN 107548398 A CN107548398 A CN 107548398A CN 201680021488 A CN201680021488 A CN 201680021488A CN 107548398 A CN107548398 A CN 107548398A
Authority
CN
China
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
mycobacterium
formula iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680021488.3A
Other languages
English (en)
Chinese (zh)
Inventor
M.R.K.阿利
D.巴罗斯-阿圭尔
I.焦尔达诺
V.埃尔南德斯
李先锋
J.J.普拉特纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property No 2 Ltd
Anacor Pharmaceuticals LLC
Original Assignee
GlaxoSmithKline Intellectual Property No 2 Ltd
Anacor Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55409879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN107548398(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GlaxoSmithKline Intellectual Property No 2 Ltd, Anacor Pharmaceuticals LLC filed Critical GlaxoSmithKline Intellectual Property No 2 Ltd
Publication of CN107548398A publication Critical patent/CN107548398A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201680021488.3A 2015-02-12 2016-02-12 苯并氧杂硼杂环戊烯化合物及其用途 Pending CN107548398A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP15382056.8 2015-02-12
EP15382055.0 2015-02-12
EP15382055 2015-02-12
EP15382056 2015-02-12
EP15382054.3 2015-02-12
EP15382054 2015-02-12
PCT/IB2016/050776 WO2016128949A1 (en) 2015-02-12 2016-02-12 Benzoxaborole compounds and uses thereof

Publications (1)

Publication Number Publication Date
CN107548398A true CN107548398A (zh) 2018-01-05

Family

ID=55409879

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201680021488.3A Pending CN107548398A (zh) 2015-02-12 2016-02-12 苯并氧杂硼杂环戊烯化合物及其用途
CN201680021538.8A Active CN107531730B (zh) 2015-02-12 2016-02-12 4-取代苯并氧杂硼杂环戊烯化合物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680021538.8A Active CN107531730B (zh) 2015-02-12 2016-02-12 4-取代苯并氧杂硼杂环戊烯化合物及其用途

Country Status (36)

Country Link
US (3) US20180037595A1 (enExample)
EP (2) EP3256480A1 (enExample)
JP (2) JP2018506540A (enExample)
KR (2) KR20170117158A (enExample)
CN (2) CN107548398A (enExample)
AU (3) AU2016217508A1 (enExample)
BR (2) BR112017017211B1 (enExample)
CA (2) CA2976030C (enExample)
CL (2) CL2017002060A1 (enExample)
CO (2) CO2017008816A2 (enExample)
CR (2) CR20170371A (enExample)
CY (1) CY1123687T1 (enExample)
DK (1) DK3256479T3 (enExample)
DO (2) DOP2017000189A (enExample)
EA (2) EA036516B1 (enExample)
ES (1) ES2821951T3 (enExample)
HR (1) HRP20201597T1 (enExample)
HU (1) HUE051113T2 (enExample)
IL (2) IL253864B (enExample)
LT (1) LT3256479T (enExample)
MA (2) MA41495A (enExample)
MX (2) MX379057B (enExample)
MY (1) MY194004A (enExample)
NZ (1) NZ734379A (enExample)
PE (2) PE20171432A1 (enExample)
PH (2) PH12017501427A1 (enExample)
PL (1) PL3256479T3 (enExample)
PT (1) PT3256479T (enExample)
RS (1) RS60885B1 (enExample)
SG (2) SG11201706511TA (enExample)
SI (1) SI3256479T1 (enExample)
SM (1) SMT202000565T1 (enExample)
TW (2) TWI730953B (enExample)
UA (1) UA120527C2 (enExample)
WO (2) WO2016128949A1 (enExample)
ZA (1) ZA201705456B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160251380A1 (en) * 2013-08-09 2016-09-01 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof
DK3621609T3 (da) 2017-05-08 2022-08-29 Glaxosmithkline Ip Dev Ltd Sanfetrinem eller et salt eller ester deraf til anvendelse i behandling af mykobakterieinfektion
MX2020005464A (es) 2017-11-30 2020-12-03 Boragen Inc Compuestos de benzoxaborol y formulaciones de los mismos.
EP3836938A4 (en) 2018-08-18 2022-05-11 Boragen, Inc. SOLID FORMS OF SUBSTITUTED BENZOXAZOLE AND COMPOSITIONS THEREOF
CN110441344B (zh) * 2019-06-25 2020-09-29 北京大学 一种基于固体核磁共振技术检测rna结构的方法
CA3239097A1 (en) 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Prodrugs of boron compounds and their use in treating bacterial infections
JP2025520237A (ja) * 2022-06-23 2025-07-03 ミクウルク ファーマシューティカルズ, インコーポレイテッド ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
KR20240150582A (ko) 2023-04-08 2024-10-15 김태서 맥세이프 배터리팩을 포함한 아이폰 케이스

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1155286A (zh) * 1994-06-09 1997-07-23 曾尼卡有限公司 氧杂硼杂环戊烯及其盐,和它们作为生物杀伤剂的用途
CN101772302A (zh) * 2007-06-20 2010-07-07 安纳考尔医药公司 含硼小分子
WO2011037731A1 (en) * 2009-09-25 2011-03-31 Anacor Pharmaceuticals, Inc. Boron containing small molecules
CN102821609A (zh) * 2010-04-07 2012-12-12 葛兰素史密丝克莱恩有限责任公司 用于制备苯并氧杂硼杂环戊烯的方法
CN103140228A (zh) * 2010-09-07 2013-06-05 阿纳科制药公司 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
CN104136032A (zh) * 2011-12-22 2014-11-05 盟科医药技术公司 可用于抗菌治疗的三环类硼化合物
WO2015021396A2 (en) * 2013-08-09 2015-02-12 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024753A1 (en) 1996-12-02 1998-06-11 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US7446236B2 (en) 2002-12-02 2008-11-04 Solvias Ag Catalytic hydrogenation of carbon-heteroatom double bonds
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
ES2872962T3 (es) 2005-02-16 2021-11-03 Anacor Pharmaceuticals Inc Boronoftalidas para uso terapéutico
JP5084717B2 (ja) 2005-03-08 2012-11-28 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ キラル・ビスオキサゾリン触媒
TWM325238U (en) * 2006-12-29 2008-01-11 Universal Scient Ind Co Ltd Voltage regulator and voltage regulating system
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
SG172040A1 (en) 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
CN102739587B (zh) 2012-06-16 2014-05-21 天地融科技股份有限公司 音频数据传输方法
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1155286A (zh) * 1994-06-09 1997-07-23 曾尼卡有限公司 氧杂硼杂环戊烯及其盐,和它们作为生物杀伤剂的用途
CN101772302A (zh) * 2007-06-20 2010-07-07 安纳考尔医药公司 含硼小分子
WO2011037731A1 (en) * 2009-09-25 2011-03-31 Anacor Pharmaceuticals, Inc. Boron containing small molecules
CN102821609A (zh) * 2010-04-07 2012-12-12 葛兰素史密丝克莱恩有限责任公司 用于制备苯并氧杂硼杂环戊烯的方法
CN103140228A (zh) * 2010-09-07 2013-06-05 阿纳科制药公司 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
CN104136032A (zh) * 2011-12-22 2014-11-05 盟科医药技术公司 可用于抗菌治疗的三环类硼化合物
WO2015021396A2 (en) * 2013-08-09 2015-02-12 Glaxosmithkline Intellectual Property (No.2) Limited Tricyclic benzoxaborole compounds and uses thereof

Also Published As

Publication number Publication date
HRP20201597T1 (hr) 2020-12-25
CN107531730B (zh) 2020-08-07
EA201791667A1 (ru) 2018-02-28
HUE051113T2 (hu) 2021-01-28
US10774096B2 (en) 2020-09-15
NZ734379A (en) 2023-06-30
MY194004A (en) 2022-11-07
WO2016128948A1 (en) 2016-08-18
LT3256479T (lt) 2020-12-28
KR20170117156A (ko) 2017-10-20
SG11201706511TA (en) 2017-09-28
SMT202000565T1 (it) 2020-11-10
CY1123687T1 (el) 2022-03-24
TW201702250A (zh) 2017-01-16
CO2017008809A2 (es) 2017-11-10
PH12017501428A1 (en) 2018-01-15
CA2976308A1 (en) 2016-08-18
CO2017008816A2 (es) 2017-11-10
BR112017017211A2 (pt) 2018-04-03
JP2018506538A (ja) 2018-03-08
JP6771472B2 (ja) 2020-10-21
DOP2017000189A (es) 2018-02-15
MX2017010414A (es) 2018-05-11
IL253865A0 (en) 2017-10-31
KR20170117158A (ko) 2017-10-20
US11214582B2 (en) 2022-01-04
JP2018506540A (ja) 2018-03-08
TW201643173A (zh) 2016-12-16
PH12017501427A1 (en) 2018-01-15
MX379057B (es) 2025-03-10
US20180037595A1 (en) 2018-02-08
PT3256479T (pt) 2020-10-22
SI3256479T1 (sl) 2020-11-30
BR112017017211B1 (pt) 2023-04-25
MA41495A (fr) 2017-12-19
CA2976030C (en) 2023-09-26
PL3256479T3 (pl) 2021-06-14
EP3256480A1 (en) 2017-12-20
AU2016217508A1 (en) 2017-09-28
AU2020256369A1 (en) 2020-11-12
IL253864B (en) 2021-07-29
MX2017010413A (es) 2018-05-11
UA120527C2 (uk) 2019-12-26
AU2016217507B2 (en) 2019-03-14
EA201791671A1 (ru) 2018-02-28
WO2016128949A1 (en) 2016-08-18
CA2976030A1 (en) 2016-08-18
EP3256479A1 (en) 2017-12-20
TWI730953B (zh) 2021-06-21
MA41494B1 (fr) 2020-10-28
DK3256479T3 (da) 2020-11-02
MA41494A (fr) 2017-12-19
EP3256479B1 (en) 2020-07-29
US20210053996A1 (en) 2021-02-25
ZA201705456B (en) 2019-10-30
SG11201706510YA (en) 2017-09-28
BR112017017213A2 (pt) 2018-04-03
CR20170371A (es) 2018-01-22
IL253864A0 (en) 2017-09-28
RS60885B1 (sr) 2020-11-30
PE20171348A1 (es) 2017-09-13
DOP2017000188A (es) 2017-09-15
US20180044353A1 (en) 2018-02-15
PE20171432A1 (es) 2017-09-26
AU2016217507A1 (en) 2017-09-28
CN107531730A (zh) 2018-01-02
CR20170372A (es) 2017-10-19
ES2821951T3 (es) 2021-04-28
EA036516B1 (ru) 2020-11-18
CL2017002060A1 (es) 2018-03-16
CL2017002059A1 (es) 2018-03-16

Similar Documents

Publication Publication Date Title
JP6764970B2 (ja) 三環式ベンゾキサボロール化合物及びその使用
CN107531730B (zh) 4-取代苯并氧杂硼杂环戊烯化合物及其用途
EA038093B1 (ru) Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
HK1219939B (en) Tricyclic benzoxaborole compounds and uses thereof
OA17674A (en) Tricyclic benzoxaborole compounds and uses thereof.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180105